ARCHIVES

QOL With Femara Comparable To Placebo, Analysis Finds

This article is from The Cancer Letter archive.

Vol. 26 No. 12 | December 26, 2003

Download PDF Visit The Full Archive

Related Articles

Nancy Brinker Resigns As CEO of Komen

August 10, 2012

Interim NSABP Leaders Will Not Nominate Chairman, Citing Exec. Committee “Bias”

September 9, 1994

NIH Guidelines Define Eligible Research Using Stem Cells.

September 8, 2000

Abstracts Of ‘Most Newsworthy’ Papers

June 10, 1977

DCPC Board Defers Two Concepts More Approvals Listed

October 19, 1984

In Brief: Broder Wins ARC’s Griffuel Prize; Lawyers Trained To Help Low-Income Breast Ca, Patients

October 16, 1992